Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0MV0T
|
||||
| Former ID |
DNC013100
|
||||
| Drug Name |
2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528402] | ||
| Formula |
C11H11N3
|
||||
| Canonical SMILES |
C1CC2=NC3=CC=CC=C3C(=N)N2C1
|
||||
| InChI |
1S/C11H11N3/c12-11-8-4-1-2-5-9(8)13-10-6-3-7-14(10)11/h1-2,4-5,12H,3,6-7H2
|
||||
| InChIKey |
AOSPPBURKIEYRC-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [528402] | |
| Cholinesterase | Target Info | Inhibitor | [528402] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||